Cardiff Oncology Inc
SWB:XE7C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
X
|
Xior Student Housing NV
LSE:0RD8
|
BE |
|
Avi Ltd
F:IZ60
|
ZA |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
F
|
Firefinch Ltd
F:N9F
|
AU |
|
U
|
UPM-Kymmene Oyj
F:RPL
|
FI |
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
S
|
Schroders PLC
XBER:PYXA
|
UK |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
Shareholder Yield
Current shareholder yield for 
XE7C is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
XE7C Price
Cardiff Oncology Inc
| Average Annual Return | 27.67% |
| Standard Deviation of Annual Returns | 125.09% |
| Max Drawdown | -88% |
| Market Capitalization | 110m EUR |
| Shares Outstanding | 44 720 000 |
| Percentage of Shares Shorted |
N/A
|
XE7C Return Decomposition
Main factors of price return
Stock Splits
XE7C's latest stock split occurred on Feb 20, 2019
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
The adjusted shares began trading on Feb 20, 2019. This was stock split number 2 in XE7C's history, following the previous one in Jun 4, 2018.
